| 1 | Oophoritis | 36.6% |
| 2 | Ovarian Hyperstimulation Syndrome | 32.8% |
| 3 | Parathyroid Neoplasms | 31.5% |
| 4 | Thyroid Neoplasm | 31.5% |
| 5 | Thyroid carcinoma | 31.5% |
| 6 | Corpus Luteum Cyst | 31.5% |
| 7 | Ovarian Cysts | 31.5% |
| 8 | Adrenal Gland Neoplasms | 30.4% |
| 9 | Anovulation | 28.6% |
| 10 | Fallopian Tube Neoplasms | 25.8% |
| 11 | Testicular Neoplasms | 25.8% |
| 12 | Uterine Neoplasms | 24.6% |
| 13 | Vaginal Neoplasms | 24.6% |
| 14 | Vulvar Neoplasms | 24.6% |
| 15 | Uterine Cancer | 24.6% |
| 16 | Multiple Endocrine Neoplasia | 23.8% |
| 17 | Pancreatic Neoplasm | 23.8% |
| 18 | Polycystic Ovary Syndrome | 23.4% |
| 19 | Thyroid Nodule | 22.8% |
| 20 | Pituitary Adenoma | 19.8% |
| 21 | Pituitary Neoplasms | 19.8% |
| 22 | Prolactinoma | 18.4% |
| 23 | Growth Hormone-Secreting Pituitary Adenoma | 18.4% |
| 24 | Salpingitis | 18.3% |
| 25 | Endometrial Neoplasms | 18.2% |
| 26 | Adrenocortical carcinoma | 17.6% |
| 27 | Urologic Neoplasms | 17% |
| 28 | Endometritis | 16.9% |
| 29 | Multiple Endocrine Neoplasia Type 1 | 16.9% |
| 30 | Hermaphroditism | 15.9% |
| 31 | Disorders of Sex Development | 15.9% |
| 32 | Nelson Syndrome | 15.8% |
| 33 | Carcinoma, Pancreatic Ductal | 15.5% |
| 34 | Leydig Cell Tumor | 15.3% |
| 35 | Endometriosis | 14.7% |
| 36 | Uterine Diseases | 14.7% |
| 37 | Vaginal Diseases | 14.7% |
| 38 | Vulvar Diseases | 14.7% |
| 39 | Endometrioma | 14.7% |
| 40 | Hypogonadism | 14.6% |
| 41 | Delayed Puberty | 14.6% |
| 42 | Precocious Puberty | 14.6% |
| 43 | Hypogonadotropic hypogonadism | 14.6% |
| 44 | Testotoxicosis | 14.6% |
| 45 | Premature Menopause | 14.5% |
| 46 | Urologic Diseases | 14.1% |
| 47 | Adnexitis | 13.5% |
| 48 | Pelvic Inflammatory Disease | 13.5% |
| 49 | insulinoma | 13.5% |
| 50 | Gastrinoma | 13.4% |
| 51 | Glucagonoma | 13.4% |
| 52 | Vipoma | 12.8% |
| 53 | Infertility | 12.7% |
| 54 | Adrenal Gland Diseases | 12.6% |
| 55 | Parathyroid Diseases | 12.6% |
| 56 | Thyroid Diseases | 12.6% |
| 57 | Testicular Diseases | 12.6% |
| 58 | Bladder Neoplasm | 12.5% |
| 59 | Kidney Neoplasm | 12.5% |
| 60 | Ureteral Neoplasms | 12.5% |
| 61 | Urethral Neoplasms | 12.5% |
| 62 | Urogenital Abnormalities | 12.4% |
| 63 | Carcinoma, Endometrioid | 12.4% |
| 64 | Endometrial Stromal Sarcoma | 12% |
| 65 | Kallmann Syndrome | 11.8% |
| 66 | Bone Diseases, Endocrine | 10.9% |
| 67 | Vulvovaginitis | 10.8% |
| 68 | Diabetes Mellitus | 10.8% |
| 69 | Hyperandrogenism | 10.7% |
| 70 | Klinefelter Syndrome | 10.7% |
| 71 | Parametritis | 10.7% |
| 72 | Pituitary Diseases | 10.7% |
| 73 | Gonadal Dysgenesis | 10.5% |
| 74 | Adrenogenital Syndrome | 10.5% |
| 75 | Ovotesticular Disorders of Sex Development | 10.5% |
| 76 | Uterine Inversion | 10.4% |
| 77 | Diabetes Insipidus | 10.2% |
| 78 | Sexually Transmitted Diseases | 10.2% |
| 79 | Abdominal Neoplasms | 10.1% |
| 80 | Head and Neck Neoplasms | 10.1% |
| 81 | Soft Tissue Neoplasms | 10.1% |
| 82 | Thoracic Neoplasms | 10.1% |
| 83 | Pregnancy Complications | 10% |
| 84 | Denys-Drash Syndrome | 9.9% |
| 85 | Gestational Diabetes | 9.9% |
| 86 | Genital Herpes | 9.8% |
| 87 | Nephroblastoma | 9.7% |
| 88 | Mesoblastic Nephroma | 9.6% |
| 89 | Pregnancy Complications, Neoplastic | 9.6% |
| 90 | Dwarfism | 9.5% |
| 91 | Genital Neoplasms, Female | 9.3% |
| 92 | Uterine Rupture | 9.2% |
| 93 | Renal Cell Carcinoma | 9.2% |
| 94 | Papillary Renal Cell Carcinoma | 9.2% |
| 95 | Endometrial Hyperplasia | 9.1% |
| 96 | Pyometra | 9.1% |
| 97 | Vaginitis | 9.1% |
| 98 | Vulvitis | 9.1% |
| 99 | Vaginal Discharge | 9.1% |
| 100 | Vulvodynia | 9.1% |
| 101 | Bladder Exstrophy | 9% |
| 102 | Epispadias | 9% |
| 103 | Peritoneal Neoplasms | 9% |
| 104 | Tuberculosis, Renal | 9% |
| 105 | Digestive System Neoplasms | 8.9% |
| 106 | Eye Neoplasms | 8.9% |
| 107 | Nervous System Neoplasms | 8.9% |
| 108 | Bone neoplasms | 8.7% |
| 109 | Skin Neoplasms | 8.7% |
| 110 | Hematologic Neoplasms | 8.7% |
| 111 | Splenic Neoplasms | 8.6% |
| 112 | Vesicovaginal Fistula | 8.6% |
| 113 | Orchitis | 8.6% |
| 114 | Diabetic Nephropathy | 8.5% |
| 115 | Congenital Hypothyroidism | 8% |
| 116 | Multicystic Dysplastic Kidney | 8% |
| 117 | Urinary Bladder Diseases | 7.9% |
| 118 | Kidney Diseases | 7.9% |
| 119 | Ureteral Diseases | 7.9% |
| 120 | Urethral Diseases | 7.9% |
| 121 | Urination Disorders | 7.9% |
| 122 | Urolithiasis | 7.9% |
| 123 | Tracheal Neoplasms | 7.9% |
| 124 | Adrenal Cortex Diseases | 7.8% |
| 125 | Euthyroid Sick Syndromes | 7.8% |
| 126 | Goiter | 7.8% |
| 127 | Hyperparathyroidism | 7.8% |
| 128 | Hyperthyroidism | 7.8% |
| 129 | Hyperthyroxinemia | 7.8% |
| 130 | Hypoparathyroidism | 7.8% |
| 131 | Hypothyroidism | 7.8% |
| 132 | Thyroiditis | 7.8% |
| 133 | Secondary hypothyroidism | 7.8% |
| 134 | Primary Hyperthyroidism | 7.8% |
| 135 | Primary Hypothyroidism | 7.8% |
| 136 | Pruritus Vulvae | 7.8% |
| 137 | Uterine hemorrhage | 7.8% |
| 138 | Vaginal Fistula | 7.8% |
| 139 | Uterine Prolapse | 7.8% |
| 140 | Vaginal Prolapse | 7.8% |
| 141 | Turner Syndrome | 7.8% |
| 142 | Anuria | 7.7% |
| 143 | Ureterolithiasis | 7.7% |
| 144 | Nephrolithiasis | 7.7% |
| 145 | Paraneoplastic Encephalomyelitis | 7.6% |
| 146 | Mammary Neoplasms, Experimental | 7.5% |
| 147 | Graves Disease | 7.4% |
| 148 | Candidiasis, Vulvovaginal | 7.4% |
| 149 | Acanthoma | 7.1% |
| 150 | Uterine Cervical Incompetence | 7% |
| 151 | Urinary tract infection | 7% |
| 152 | ovarian neoplasm | 7% |
| 153 | Esophageal Neoplasms | 7% |
| 154 | Urinary Bladder Fistula | 6.9% |
| 155 | Horseshoe Kidney | 6.9% |
| 156 | Dyspareunia | 6.9% |
| 157 | Gonadal Disorders | 6.9% |
| 158 | Cryptorchidism | 6.7% |
| 159 | Ovarian Diseases | 6.7% |
| 160 | Empty Sella Syndrome | 6.7% |
| 161 | Hyperpituitarism | 6.7% |
| 162 | Hypopituitarism | 6.7% |
| 163 | Hypophysitis | 6.7% |
| 164 | Retroperitoneal Neoplasms | 6.6% |
| 165 | Bladder neck obstruction | 6.6% |
| 166 | Trophoblastic Neoplasms | 6.5% |
| 167 | Carcinoma, Lobular | 6.4% |
| 168 | Uterine Cervicitis | 6.3% |
| 169 | Leukorrhea | 6.3% |
| 170 | Hypospadias | 6.1% |
| 171 | Kidney Calculi | 6.1% |
| 172 | Ureteral Calculi | 6.1% |
| 173 | Latent Autoimmune Diabetes in Adults | 5.9% |
| 174 | Diabetes Mellitus, Experimental | 5.8% |
| 175 | Diabetic Foot | 5.8% |
| 176 | Mouth Neoplasms | 5.8% |
| 177 | Central Nervous System Neoplasms | 5.8% |
| 178 | Vascular Neoplasms | 5.8% |
| 179 | Thymus Neoplasms | 5.8% |
| 180 | Hamartoma | 5.7% |
| 181 | Neoplasms, Hormone-Dependent | 5.7% |
| 182 | Neoplasms, Multiple Primary | 5.7% |
| 183 | Paraneoplastic Syndromes | 5.7% |
| 184 | Precancerous Conditions | 5.7% |
| 185 | Neoplasms, Second Primary | 5.7% |
| 186 | Meningioma | 5.7% |
| 187 | Breast Neoplasms, Male | 5.7% |
| 188 | Triple Negative Breast Neoplasms | 5.7% |
| 189 | granulosa cell tumor | 5.6% |
| 190 | Carcinoma, Ovarian Epithelial | 5.6% |
| 191 | Cushing Syndrome | 5.5% |
| 192 | Hyperaldosteronism | 5.5% |
| 193 | Hyperparathyroidism, Secondary | 5.5% |
| 194 | Hypoaldosteronism | 5.5% |
| 195 | Thyrotoxicosis | 5.5% |
| 196 | Hyperparathyroidism, Primary | 5.5% |
| 197 | Thyroid Hormone Resistance Syndrome | 5.5% |
| 198 | Bacterial Vaginosis | 5.5% |
| 199 | Acoustic Neuroma | 5.4% |
| 200 | Trichomonas Vaginitis | 5.4% |
| 201 | Uterine Perforation | 5.4% |
| 202 | Metrorrhagia | 5.4% |
| 203 | Thymoma | 5.4% |
| 204 | Chorioamnionitis | 5.4% |
| 205 | Polyhydramnios | 5.3% |
| 206 | Obstetric Labor Complications | 5.3% |
| 207 | Ectopic Pregnancy | 5.3% |
| 208 | Pregnancy, Prolonged | 5.3% |
| 209 | Puerperal Disorders | 5.3% |
| 210 | Oligohydramnios | 5.3% |
| 211 | Prenatal Injuries | 5.3% |
| 212 | Abruptio Placentae | 5.2% |
| 213 | Placenta Accreta | 5.2% |
| 214 | Pituitary Apoplexy | 5.1% |
| 215 | Gastrointestinal Neoplasms | 5.1% |
| 216 | Genital Neoplasms, Male | 5.1% |
| 217 | Liver neoplasms | 5.1% |
| 218 | Uveal Neoplasms | 5.1% |
| 219 | Nose Neoplasms | 5.1% |
| 220 | Renal Osteodystrophy | 5% |
| 221 | Renal rickets | 5% |
| 222 | Liver Neoplasms, Experimental | 5% |
| 223 | Sebaceous Gland Neoplasms | 5% |
| 224 | Spinal Neoplasms | 5% |
| 225 | Bone Marrow Neoplasms | 5% |
| 226 | Cystitis | 5% |
| 227 | Hydronephrosis | 5% |
| 228 | Hyperoxaluria | 5% |
| 229 | Kidney Cortex Necrosis | 5% |
| 230 | Kidney Papillary Necrosis | 5% |
| 231 | Nephritis | 5% |
| 232 | Nephrosclerosis | 5% |
| 233 | Nephrosis | 5% |
| 234 | Perinephritis | 5% |
| 235 | Kidney Failure | 5% |
| 236 | Uremia | 5% |
| 237 | Ureteral obstruction | 5% |
| 238 | Ureterocele | 5% |
| 239 | Urethral Obstruction | 5% |
| 240 | Urethritis | 5% |
| 241 | Vesico-Ureteral Reflux | 5% |
| 242 | Urinary Retention | 5% |
| 243 | Oxalosis | 5% |
| 244 | Renal Insufficiency | 5% |
| 245 | Cyst | 4.9% |
| 246 | Endocrine Gland Neoplasms | 4.9% |
| 247 | Neoplastic Processes | 4.9% |
| 248 | Neoplastic Syndromes, Hereditary | 4.9% |
| 249 | Palatal Neoplasms | 4.9% |
| 250 | Neoplasms, Experimental | 4.9% |
| 251 | Pyelocystitis | 4.9% |
| 252 | Addison Disease | 4.8% |
| 253 | Diabetic Angiopathies | 4.8% |
| 254 | Autoimmune thyroiditis | 4.8% |
| 255 | Primary Adrenal Insufficiency | 4.8% |
| 256 | Leukoplakia, Oral | 4.8% |
| 257 | Carcinoma 256, Walker | 4.8% |
| 258 | Paraneoplastic Cerebellar Degeneration | 4.8% |
| 259 | Diabetic Neuropathies | 4.8% |
| 260 | Myxedema | 4.8% |
| 261 | Diabetic Amyotrophy | 4.8% |
| 262 | Diabetic Autonomic Neuropathy | 4.8% |
| 263 | Diabetic Cardiomyopathies | 4.8% |
| 264 | Choriocarcinoma | 4.7% |
| 265 | Menorrhagia | 4.7% |
| 266 | Hyperprolactinemia | 4.7% |
| 267 | Fetal Diseases | 4.7% |
| 268 | Pregnancy Complications, Cardiovascular | 4.7% |
| 269 | Retinoblastoma | 4.7% |
| 270 | Pregnancy Complications, Hematologic | 4.6% |
| 271 | Pregnancy Complications, Infectious | 4.6% |
| 272 | Optic Nerve Glioma | 4.6% |
| 273 | Puerperal Infection | 4.6% |
| 274 | Fetal Death | 4.6% |
| 275 | Perinatal death | 4.6% |
| 276 | Postpartum Hemorrhage | 4.6% |
| 277 | Morning Sickness | 4.5% |
| 278 | Melanoma, Experimental | 4.4% |
| 279 | Hyperglycemic Hyperosmolar Nonketotic Coma | 4.4% |
| 280 | Hashimoto Disease | 4.4% |
| 281 | Hepatocellular Adenoma | 4.4% |
| 282 | Hepatorenal Syndrome | 4.4% |
| 283 | Bacteriuria | 4.3% |
| 284 | Glycosuria | 4.3% |
| 285 | Hematuria | 4.3% |
| 286 | Renal hypertension | 4.3% |
| 287 | Oliguria | 4.3% |
| 288 | Polyuria | 4.3% |
| 289 | Proteinuria | 4.3% |
| 290 | Pyuria | 4.3% |
| 291 | Renal Artery Obstruction | 4.3% |
| 292 | Renal Artery Stenosis | 4.3% |
| 293 | Urinary Calculi | 4.3% |
| 294 | Tuberous Sclerosis | 4.3% |
| 295 | Pyelonephritis | 4.3% |
| 296 | Cystocele | 4.3% |
| 297 | Nephrocalcinosis | 4.3% |
| 298 | Urinary Incontinence | 4.3% |
| 299 | Carcinoma, Ehrlich Tumor | 4.3% |
| 300 | Dermoid Cyst | 4.3% |
| 301 | Carcinoma, Lewis Lung | 4.3% |
| 302 | Limbic Encephalitis | 4.3% |
| 303 | Neoplasms, Radiation-Induced | 4.3% |
| 304 | Meningeal Neoplasms | 4.3% |
| 305 | Leukemia, Experimental | 4.2% |
| 306 | Gigantism | 4.2% |
| 307 | Acromegaly | 4.1% |
| 308 | Neoplasms, Neuroepithelial | 4.1% |
| 309 | Gliomatosis cerebri | 4.1% |
| 310 | Diabetic Ketoacidosis | 4.1% |
| 311 | Medulloblastoma | 4.1% |
| 312 | Glycosuria, Renal | 4.1% |
| 313 | Lambert-Eaton Myasthenic Syndrome | 3.9% |
| 314 | Enuresis | 3.9% |
| 315 | Neuroectodermal Tumors | 3.8% |
| 316 | Ear Neoplasms | 3.8% |
| 317 | Eyelid Neoplasms | 3.8% |
| 318 | Lung Neoplasms | 3.8% |
| 319 | Pleural Neoplasms | 3.8% |
| 320 | Chlamydia Infections | 3.8% |
| 321 | Gonorrhea | 3.8% |
| 322 | Sarcoma, Experimental | 3.7% |
| 323 | Leukemia, Radiation-Induced | 3.7% |
| 324 | Brain Neoplasms | 3.7% |
| 325 | Salivary Gland Neoplasms | 3.7% |
| 326 | Spinal Cord Neoplasms | 3.7% |
| 327 | Tongue Neoplasms | 3.7% |
| 328 | melanoma | 3.7% |
| 329 | Opsoclonus-Myoclonus Syndrome | 3.6% |
| 330 | Adenomatous Polyposis Coli | 3.6% |
| 331 | Glomerulonephritis | 3.5% |
| 332 | Nephritis, Interstitial | 3.5% |
| 333 | Lipoid nephrosis | 3.5% |
| 334 | Nephrotic Syndrome | 3.5% |
| 335 | Pyelitis | 3.5% |
| 336 | Pyonephrosis | 3.5% |
| 337 | Urethral Stenosis | 3.5% |
| 338 | Nephrogenic Diabetes Insipidus | 3.5% |
| 339 | Meningeal Carcinomatosis | 3.5% |
| 340 | Congenital Nephrogenic Diabetes Insipidus | 3.5% |
| 341 | Acute kidney injury | 3.5% |
| 342 | Urethral stricture | 3.5% |
| 343 | AIDS-Associated Nephropathy | 3.5% |
| 344 | Syphilis | 3.4% |
| 345 | Pharyngeal Neoplasms | 3.4% |
| 346 | Erythroplasia | 3.4% |
| 347 | Follicular cyst | 3.4% |
| 348 | leukemia | 3.4% |
| 349 | Mucocele | 3.4% |
| 350 | Neoplasms, Germ Cell and Embryonal | 3.4% |
| 351 | Neoplasms, Glandular and Epithelial | 3.4% |
| 352 | Pilonidal Cyst | 3.4% |
| 353 | Thyroglossal Cyst | 3.4% |
| 354 | Synovial Cyst | 3.4% |
| 355 | Germ Cell Cancer | 3.4% |
| 356 | Aberrant Crypt Foci | 3.4% |
| 357 | Diabetic Retinopathy | 3.3% |
| 358 | Central Nervous System Cysts | 3.3% |
| 359 | Bile Duct Neoplasms | 3.3% |
| 360 | gallbladder neoplasm | 3.3% |
| 361 | Intestinal Neoplasms | 3.3% |
| 362 | Penile Neoplasms | 3.3% |
| 363 | Prostatic Neoplasms | 3.3% |
| 364 | Stomach Neoplasms | 3.3% |
| 365 | Carcinosarcoma | 3.3% |
| 366 | Hemangiosarcoma | 3.3% |
| 367 | Leukemia L1210 | 3.3% |
| 368 | Leukemia P388 | 3.3% |
| 369 | lymphangiosarcoma | 3.3% |
| 370 | Myelitis, Transverse | 3.3% |
| 371 | Polycythemia Vera | 3.3% |
| 372 | Adenoma, Acidophil | 3.3% |
| 373 | Ganglioneuroma | 3.3% |
| 374 | Glioma | 3.3% |
| 375 | Hydatidiform Mole | 3.3% |
| 376 | Malignant Glioma | 3.3% |
| 377 | Basal Cell Nevus Syndrome | 3.2% |
| 378 | Bronchial Neoplasms | 3.1% |
| 379 | Azotemia | 3.1% |
| 380 | Lymphomatoid Granulomatosis | 3.1% |
| 381 | Multiple Pulmonary Nodules | 3.1% |
| 382 | Albuminuria | 3.1% |
| 383 | Hemoglobinuria | 3.1% |
| 384 | Hypertension, Renovascular | 3.1% |
| 385 | Supratentorial Neoplasms | 3.1% |
| 386 | Urge Incontinence | 3.1% |
| 387 | Laryngeal neoplasm | 3.1% |
| 388 | Sarcoma 180 | 3.1% |
| 389 | Carcinoid Tumor | 3.1% |
| 390 | Neurilemmoma | 3.1% |
| 391 | Hutchinson's Melanotic Freckle | 3.1% |
| 392 | Melanoma, Amelanotic | 3.1% |
| 393 | Abortion, Habitual | 3% |
| 394 | Dystocia | 3% |
| 395 | Eclampsia | 3% |
| 396 | Fetal Membranes, Premature Rupture | 3% |
| 397 | Placental Insufficiency | 3% |
| 398 | Pre-Eclampsia | 3% |
| 399 | Prenatal Exposure Delayed Effects | 3% |
| 400 | HELLP Syndrome | 3% |
| 401 | Placenta, Retained | 3% |
| 402 | Composite Lymphoma | 2.9% |
| 403 | Lymphogranuloma Venereum | 2.9% |
| 404 | Leukoplakia | 2.9% |
| 405 | Lymphocele | 2.9% |
| 406 | Pancreatic Cyst | 2.9% |
| 407 | Leukemia, Plasma Cell | 2.9% |
| 408 | Barrett Esophagus | 2.9% |
| 409 | Breast Cyst | 2.9% |
| 410 | Histiocytic Disorders, Malignant | 2.9% |
| 411 | Actinic keratosis | 2.9% |
| 412 | Mediastinal Cyst | 2.9% |
| 413 | Neoplasm Invasiveness | 2.9% |
| 414 | Neoplasm Metastasis | 2.9% |
| 415 | Neoplasm Recurrence, Local | 2.9% |
| 416 | Parovarian Cyst | 2.9% |
| 417 | Pericardial Cyst | 2.9% |
| 418 | Thymic Cyst | 2.9% |
| 419 | Carcinogenesis | 2.9% |
| 420 | Myxoid cyst | 2.9% |
| 421 | Metastasis | 2.9% |
| 422 | Astrocytoma | 2.9% |
| 423 | Ependymoma | 2.9% |
| 424 | oligodendroglioma | 2.9% |
| 425 | Ganglioglioma | 2.9% |
| 426 | gliosarcoma | 2.9% |
| 427 | Anaplastic astrocytoma | 2.9% |
| 428 | Anaplastic Oligodendroglioma | 2.9% |
| 429 | Basal cell carcinoma | 2.8% |
| 430 | Carcinoma, Papillary | 2.8% |
| 431 | Squamous cell carcinoma | 2.8% |
| 432 | Chondrosarcoma | 2.8% |
| 433 | Craniopharyngioma | 2.8% |
| 434 | Cystadenoma | 2.8% |
| 435 | leiomyosarcoma | 2.8% |
| 436 | liposarcoma | 2.8% |
| 437 | Mesothelioma | 2.8% |
| 438 | synovial sarcoma | 2.8% |
| 439 | Neuroectodermal Tumor, Melanotic | 2.8% |
| 440 | Angiomyolipoma | 2.8% |
| 441 | Clear Cell Sarcoma of Soft Tissue | 2.8% |
| 442 | Alveolar Soft Part Sarcoma | 2.8% |
| 443 | Neuroendocrine Tumors | 2.8% |
| 444 | Sarcoma, Myeloid | 2.8% |
| 445 | Carcinoma, Basal Cell | 2.8% |
| 446 | Balkan Nephropathy | 2.8% |
| 447 | Focal glomerulosclerosis | 2.8% |
| 448 | Kidney Failure, Chronic | 2.8% |
| 449 | Hypopharyngeal Neoplasms | 2.8% |
| 450 | Pleural Effusion, Malignant | 2.8% |
| 451 | Hypopharyngeal Cancer | 2.8% |
| 452 | Brain Stem Neoplasms | 2.8% |
| 453 | Polycystic Kidney Diseases | 2.7% |
| 454 | Malignant Carcinoid Syndrome | 2.7% |
| 455 | Diurnal Enuresis | 2.7% |
| 456 | Renal Aminoacidurias | 2.7% |
| 457 | Fanconi Syndrome | 2.7% |
| 458 | Parotid Neoplasms | 2.7% |
| 459 | Pseudohypoaldosteronism | 2.7% |
| 460 | Liddle Syndrome | 2.7% |
| 461 | Prostatic Neoplasms, Castration-Resistant | 2.7% |
| 462 | Hemolytic-Uremic Syndrome | 2.7% |
| 463 | Abortion, Veterinary | 2.7% |
| 464 | Pregnancy Complications, Parasitic | 2.7% |
| 465 | Nasopharyngeal carcinoma | 2.6% |
| 466 | Glioblastoma | 2.6% |
| 467 | Neuroblastoma | 2.6% |
| 468 | Glioblastoma Multiforme | 2.6% |
| 469 | Lactation Disorder | 2.6% |
| 470 | Mastitis | 2.6% |
| 471 | Depression, Postpartum | 2.6% |
| 472 | Embryo Loss | 2.6% |
| 473 | Fetal Resorption | 2.6% |
| 474 | Hyperemesis Gravidarum | 2.6% |
| 475 | Choroid Plexus Papilloma | 2.6% |
| 476 | Cystadenocarcinoma | 2.6% |
| 477 | Fibrosarcoma | 2.6% |
| 478 | Osteosarcoma | 2.6% |
| 479 | Mucoepidermoid Carcinoma | 2.6% |
| 480 | Ganglioneuroblastoma | 2.5% |
| 481 | Glomerulonephritis, Membranoproliferative | 2.5% |
| 482 | Lymphoma | 2.5% |
| 483 | Adenofibroma | 2.5% |
| 484 | Fibroadenoma | 2.5% |
| 485 | Malignant Fibrous Histiocytoma | 2.5% |
| 486 | Tonsillar Neoplasms | 2.5% |
| 487 | Renal tubular acidosis | 2.5% |
| 488 | Cecal Neoplasms | 2.5% |
| 489 | Duodenal Neoplasms | 2.5% |
| 490 | Cerebellar Neoplasms | 2.4% |
| 491 | Neurofibrosarcoma | 2.4% |
| 492 | Bowen's Disease | 2.3% |
| 493 | Paraganglioma | 2.3% |
| 494 | Rhabdomyosarcoma | 2.3% |
| 495 | Giant Cell Tumor of Bone | 2.3% |
| 496 | Carcinoid Heart Disease | 2.3% |
| 497 | Waterhouse-Friderichsen Syndrome | 2.3% |
| 498 | Fetal Growth Retardation | 2.3% |
| 499 | Zellweger Syndrome | 2.3% |
| 500 | Embolism, Amniotic Fluid | 2.3% |
| 501 | Fetal Hypoxia | 2.3% |
| 502 | Fetal Alcohol Spectrum Disorders | 2.3% |
| 503 | Breech Presentation | 2.3% |
| 504 | Stillbirth | 2.3% |
| 505 | Nasopharyngeal Neoplasms | 2.3% |
| 506 | Choledochal Cyst | 2.3% |
| 507 | Colorectal Neoplasms | 2.2% |
| 508 | Dermatofibrosarcoma | 2.2% |
| 509 | Dermatofibrosarcoma Protuberans | 2.2% |
| 510 | Adenoma | 2.2% |
| 511 | Ameloblastoma | 2.2% |
| 512 | Angiokeratoma | 2.2% |
| 513 | Carcinoma | 2.2% |
| 514 | Chordoma | 2.2% |
| 515 | Hemangioma | 2.2% |
| 516 | hemangiopericytoma | 2.2% |
| 517 | Lymphangioma | 2.2% |
| 518 | Mesenchymoma | 2.2% |
| 519 | Nevus | 2.2% |
| 520 | Teratoma | 2.2% |
| 521 | Hepatoblastoma | 2.2% |
| 522 | Mixed Tumor, Mullerian | 2.2% |
| 523 | Germinoma | 2.2% |
| 524 | Teratocarcinoma | 2.2% |
| 525 | Angiofibroma | 2.2% |
| 526 | Sarcoma | 2.2% |
| 527 | Epithelioma | 2.2% |
| 528 | Peutz-Jeghers Syndrome | 2.2% |
| 529 | Anti-Glomerular Basement Membrane Disease | 2.2% |
| 530 | Lupus Nephritis | 2.2% |
| 531 | Appendiceal Neoplasms | 2.2% |
| 532 | Colonic Neoplasms | 2.2% |
| 533 | Rectal Neoplasms | 2.2% |
| 534 | Lymphangioleiomyomatosis | 2.2% |
| 535 | Polycystic Kidney, Autosomal Dominant | 2.2% |
| 536 | Cystinuria | 2.2% |
| 537 | Atypical Hemolytic Uremic Syndrome | 2.2% |
| 538 | Pheochromocytoma | 2.1% |
| 539 | Alveolar rhabdomyosarcoma | 2.1% |
| 540 | Paranasal Sinus Neoplasms | 2.1% |
| 541 | Hyperphosphaturia | 2% |
| 542 | Premature Birth | 1.9% |
| 543 | Pancreatic Pseudocyst | 1.9% |
| 544 | Plasmacytoma | 1.9% |
| 545 | Malignant histiocytosis | 1.9% |
| 546 | Lymphatic Metastasis | 1.9% |
| 547 | Neoplasms, Unknown Primary | 1.9% |
| 548 | Leukemic Infiltration | 1.9% |
| 549 | Histiocytic sarcoma | 1.9% |
| 550 | Neoplasm Micrometastasis | 1.9% |
| 551 | Anus Neoplasms | 1.9% |
| 552 | Sigmoid Neoplasms | 1.9% |
| 553 | Meconium Aspiration Syndrome | 1.9% |
| 554 | Maxillary Sinus Neoplasms | 1.8% |
| 555 | Adenocarcinoma | 1.7% |
| 556 | Carcinoma in Situ | 1.7% |
| 557 | Carcinoma, Transitional Cell | 1.7% |
| 558 | Phyllodes Tumor | 1.7% |
| 559 | Dysgerminoma | 1.7% |
| 560 | Hemangioendothelioma | 1.7% |
| 561 | Lipoma | 1.7% |
| 562 | Myoma | 1.7% |
| 563 | Myxoma | 1.7% |
| 564 | Neuroma | 1.7% |
| 565 | Papilloma | 1.7% |
| 566 | Pseudomyxoma Peritonei | 1.7% |
| 567 | Seminoma | 1.7% |
| 568 | Papillomatosis | 1.7% |
| 569 | Angiolipoma | 1.7% |
| 570 | Myelolipoma | 1.7% |
| 571 | Neoplasms, Bone Tissue | 1.7% |
| 572 | Neoplasms, Fibrous Tissue | 1.7% |
| 573 | Smooth Muscle Tumor | 1.7% |
| 574 | Adenomatosis, Pulmonary | 1.7% |
| 575 | Adenomatous Polyps | 1.7% |
| 576 | Carcinoma, Large Cell | 1.7% |
| 577 | Carcinoma, Small Cell | 1.7% |
| 578 | Desmoplastic Small Round Cell Tumor | 1.7% |
| 579 | Chondroma | 1.7% |
| 580 | Enchondroma | 1.7% |
| 581 | Hodgkin Disease | 1.6% |
| 582 | Lymphoma, Non-Hodgkin | 1.6% |
| 583 | Galactorrhea | 1.6% |
| 584 | Xeroderma Pigmentosum | 1.5% |
| 585 | Adrenoleukodystrophy | 1.5% |
| 586 | Primary amyloidosis | 1.5% |
| 587 | Leukemia, Myelomonocytic, Chronic | 1.4% |
| 588 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.4% |
| 589 | Adenoid Cystic Carcinoma | 1.4% |
| 590 | fibroma | 1.4% |
| 591 | Fibromatosis | 1.4% |
| 592 | Osteoblastoma | 1.4% |
| 593 | Osteoma | 1.4% |
| 594 | Rhabdomyoma | 1.4% |
| 595 | Chondromatosis | 1.4% |
| 596 | Adenocarcinoma, Clear Cell | 1.4% |
| 597 | Cholangiocarcinoma | 1.4% |
| 598 | Cervical Intraepithelial Neoplasia | 1.4% |
| 599 | Hemangioblastoma | 1.4% |
| 600 | Lymphoma, Extranodal NK-T-Cell | 1.4% |
| 601 | Mastocytosis | 1.3% |
| 602 | Sturge-Weber Syndrome | 1.3% |
| 603 | Cell Transformation, Viral | 1.2% |
| 604 | Gastrointestinal Stromal Tumors | 1.2% |
| 605 | Hemangioma, Cavernous | 1.2% |
| 606 | Fibromatosis, Aggressive | 1.2% |
| 607 | Fibromatosis, Abdominal | 1.2% |
| 608 | Klatskin Tumor | 1.2% |
| 609 | Leukemia, T-Cell | 1.2% |
| 610 | Leukemia, B-Cell | 1.2% |
| 611 | neurofibroma | 1.2% |
| 612 | Lymphoma, Follicular | 1.2% |
| 613 | T-Cell Lymphoma | 1.2% |
| 614 | Mantle cell lymphoma | 1.2% |
| 615 | Waldenstrom Macroglobulinemia | 1.2% |
| 616 | Multiple Myeloma | 1.2% |
| 617 | Mastocytoma | 1.2% |
| 618 | Mastocytosis, Systemic | 1.2% |
| 619 | Leukemia, Myeloid, Chronic-Phase | 1.2% |
| 620 | Familial Hypophosphatemic Rickets | 1.1% |
| 621 | Zollinger-Ellison syndrome | 1.1% |
| 622 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1% |
| 623 | Leukemia, Large Granular Lymphocytic | 1% |
| 624 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1% |
| 625 | Lymphoma, T-Cell, Cutaneous | 1% |
| 626 | Lymphoma, AIDS-Related | 1% |
| 627 | Enteropathy-Associated T-Cell Lymphoma | 1% |
| 628 | Primary Effusion Lymphoma | 1% |
| 629 | Hydrops Fetalis | 1% |
| 630 | Dupuytren Contracture | 0.9% |
| 631 | Urticaria Pigmentosa | 0.9% |
| 632 | Mycosis Fungoides | 0.9% |
| 633 | Lymphomatoid Papulosis | 0.9% |
| 634 | Plasmablastic lymphoma | 0.9% |
| 635 | Burkitt Lymphoma | 0.8% |
| 636 | Sezary Syndrome | 0.7% |
| 637 | Radicular Cyst | 0.7% |
